The intellectual-property provisions included in the final agreement could delay when cost-saving generic and biosimilar medicines can enter the Canadian market, writes the president of the Canadian Generic Pharmaceutical Association.
Health Minister Ginette Petitpas Taylor’s mandate in large part is focused on improving access to necessary prescription medication and reduce the cost Canadian governments pay for these drugs, writes the president of the Canadian Generic Pharmaceutical Association.
The Hill Times file photograph by Andrew Meade
Access to affordable prescription medicines is a high priority for Canadians.
People. Policy. Politics. This is an exclusive subscriber-only story.
In a time of great uncertainty and anxiety, Dr. Theresa Tam has emerged as a 'compelling' figure who has an ability to deliver information without dramatizing the stakes. 'She gives us straightforward, evidence-based
The 'biggest point of concern right now' is 'making sure that we keep those shipments of fresh vegetables and other commodities rolling in by truck across the border, truck or train,' says John Manley.
The number of lobbying files connected to COVID-19 has exploded in the last week, with 90 registrations for 55 organizations outlining plans to push federal officials on issues ranging from policy to funding.